Evidence map›Paper›PMID 40166000›Full record

ArticleAdvances in radiation oncology2025

Domain-Adaptive and Per-Fraction Guided Deep Learning Framework for Magnetic Resonance Imaging-Based Segmentation of Organs at Risk in Gynecologic Cancers.

Reza Kalantar, Manasi Ingle, Romelie Rieu, Sebastian Curcean, Jessica Mary Winfield, Gigin Lin, Christina Messiou, Susan Lalondrelle, Dow-Mu Koh, Matthew David Blackledge

Abstract read
In one paragraph

Article in Advances in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Systematic review of artificial intelligence in brachytherapy.Journal of contemporary brachytherapy · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Reza KalantarThe Institute of Cancer Research, London, United Kingdom.
Manasi IngleThe Institute of Cancer Research, London, United Kingdom.
Romelie RieuThe Institute of Cancer Research, London, United Kingdom.
Sebastian CurceanThe Royal Marsden Hospital, London, United Kingdom.
Jessica Mary WinfieldThe Institute of Cancer Research, London, United Kingdom.
Gigin LinChang Gung Memorial Hospital, Linkou and Chang Gung University, Taoyuan, Taiwan.
Christina MessiouThe Institute of Cancer Research, London, United Kingdom.
Susan LalondrelleThe Institute of Cancer Research, London, United Kingdom.
Dow-Mu KohThe Institute of Cancer Research, London, United Kingdom.
Matthew David BlackledgeThe Institute of Cancer Research, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The integration of magnetic resonance imaging into radiation therapy (RT) treatment necessitates automated segmentation algorithms for fast and accurate adaptive interventions, particularly in magnetic resonance imaging-integrated linear accelerator (MR-linac or MRL) treatment systems. However, the scarcity of data hampers the training of these models. This study aimed to address this shortcoming by developing a synthetic MRL-assisted deep learning framework to establish a robust baseline for organ at risk segmentation on MRL images and enable domain adaptation for automatic delineations during adaptive RT treatments. Methods and Materials: We used a retrospective data set, comprising 158 patients diagnosed with various gynecologic cancers who underwent computed tomography scanning for RT planning and 25 patients with T Results: The synthetic MRL-assisted model improved organ at risk segmentation accuracy on MRL images, with fraction-adapted contours displaying high anatomical fidelity. Two radiation oncologists reported contour acceptance rates of 100% and 98% for treatment planning after adaptation. Conclusions: This novel framework holds promise to bridge the semantic gap between computed tomography and magnetic resonance imaging databases, potentially facilitating adaptive RT treatments and reducing treatment times as well as clinician burden. The utility of this framework can extend beyond gynecologic and pelvic cancers.

Identifiers

PMID40166000
PMCPMC11957591

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.